Anakinra (AKR) prophylaxis (ppx) in patients (pts) with relapsed/refractory multiple myeloma (RRMM) receiving orvacabtagene autoleucel (orva-cel) Meeting Abstract
| Authors: | Costa, L. J.; Mailankody, S.; Shaughnessy, P.; Hari, P.; Kaufman, J. L.; Larson, S. M.; Dingli, D.; Lee, K.; Conte, K.; DeVries, T.; Piasecki, J.; Li, M.; Dubowy, R. L.; Htut, M. |
| Abstract Title: | Anakinra (AKR) prophylaxis (ppx) in patients (pts) with relapsed/refractory multiple myeloma (RRMM) receiving orvacabtagene autoleucel (orva-cel) |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120601059 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.2537 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2537 -- Source: Wos |
